IPHA Competitors & Alternatives
Compare Innate Pharma with similar stocks in the same industry
Biotechnology
IPHA
Main Stock$1.56
Tradestie Score
52
Market Cap
$182.31M
Revenue Growth
0.2%
Analyst Upside
+327.4%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OABI
OmniAb, Inc. Common Stock
|
$4.87
|
$231.77M | - | 38 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.14
|
$227.00M | - | 59 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.74
|
$211.22M | - | 58 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.39
|
$202.58M | - | 50 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.32
|
$199.71M | - | 58 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.99
|
$170.45M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$7.24
|
$158.43M | - | 44 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.92
|
$154.27M | - | 68 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.94
|
$133.50M | - | 52 | Compare |
More IPHA Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry